Medtronic, Inc. v. Mirowski Family Ventures, LLC
Docket No. | Op. Below | Argument | Opinion | Vote | Author | Term |
---|---|---|---|---|---|---|
12-1128 | Fed. Cir. | Nov 5, 2013 | Jan 22, 2014 | 9-0 | Breyer | OT 2013 |
Holding: When a licensee seeks a declaratory judgment against a patentee to establish that its products do not infringe the licensed patent, the patentee bears the burden of persuasion on the issue of infringement.
Judgment: Reversed, 9-0, in an opinion by Justice Breyer on January 22, 2014.
SCOTUSblog Coverage
- Opinion analysis: Justices unimpressed with Federal Circuits mastery of federal procedure curriculum (Ronald Mann, January 23, 2014)
- Argument analysis: Justices worry that Federal Circuit has thumb on the scale for patent-holders (Ronald Mann, November 8, 2013)
- Argument preview: Federal Circuit tees one up for Justices in patent procedural dispute. (Ronald Mann, October 29, 2013)
- Court to rule on government prayer (Lyle Denniston, May 20, 2013)
- Petition of the day (Mary Pat Dwyer, May 10, 2013)
Date | Proceedings and Orders |
---|---|
03/14/2013 | Petition for a writ of certiorari filed. (Response due April 17, 2013) |
04/05/2013 | Brief of respondent Mirowski Family Ventures, LLC in opposition filed. |
04/25/2013 | Reply of petitioner Medtronic, Inc. filed. |
04/30/2013 | DISTRIBUTED for Conference of May 16, 2013. |
05/20/2013 | Petition GRANTED. |
06/05/2013 | The time to file the joint appendix and petitioner's brief on the merits is extended to and including July 26, 2013. |
06/05/2013 | The time to file respondents' brief on the merits is extended to and including September 16, 2013. |
07/26/2013 | Joint appendix filed. (Statement of costs filed.) |
07/26/2013 | Brief of petitioner Medtronic, Inc. filed. |
08/02/2013 | Brief amicus curiae of the United States filed. |
08/02/2013 | Brief amici curiae of Legal Scholars filed. |
08/02/2013 | Brief amicus curiae of Tessera Technologies, Inc. in support of neither party filed. |
08/19/2013 | CIRCULATED. |
08/20/2013 | SET FOR ARGUMENT on Tuesday, November 5, 2013. |
09/03/2013 | Record from U.S.C.A. for Federal Circuit is electronic (Not PACER). |
09/03/2013 | Additional record received from U.S.C.A. for Federal. Circuit. (1 box) |
09/11/2013 | Motion of the Solicitor General for leave to participate in oral argument as amicus curiae and for divided argument filed. |
09/16/2013 | Brief of respondent Mirowski Family Ventures, LLC filed. (Distributed) |
09/20/2013 | Motion of Tessera Technologies, Inc. in support of neither party for leave to participate in oral argument as amicus curiae and for enlarged argument or, in the alternative divided argument filed. |
09/20/2013 | Brief amicus curiae of Koninklijke Philips, N.V. filed. (Distributed) |
09/23/2013 | Brief amicus curiae of Intellectual Property Owners Association filed. (Distributed) |
09/30/2013 | Joint opposition of the parties to motion of Tessera Technologies, Inc. for leave to participate in oral argument as amicus curiae and for divided argument. |
10/15/2013 | Motion of the Solicitor General for leave to participate in oral argument as amicus curiae and for divided argument GRANTED. |
10/15/2013 | Motion of Tessera Technologies, Inc. in support of neither party for leave to participate in oral argument as amicus curiae and for divided argument DENIED. |
10/16/2013 | Reply of petitioner Medtronic, Inc. filed. (Distributed) |
11/05/2013 | Argued. For petitioner: Seth P. Waxman, Washington, D. C.; and Curtis E. Gannon, Assistant to the Solicitor General, Department of Justice, Washington, D. C. (for United States, as amicus curiae.) For respondents: Arthur I. Neustadt, Alexandria, Va. |
01/22/2014 | Judgment REVERSED and case REMANDED. Breyer, J., delivered the opinion for a unanimous Court. |
01/31/2014 | Record for U.S.C.A. for the Federal Circuit has been RETURNED. |
02/24/2014 | JUDGMENT ISSUED. |
Issue: Whether, in a declaratory judgment action brought by a licensee under”MedImmune, Inc. v. Genentech, Inc., the licensee has the burden to prove that its products do not infringe the patent, or whether (as is the case in all other patent litigation, including other declaratory judgment actions), the patentee must prove infringement.